Vitamin D bioavailability and catabolism in pediatric chronic kidney disease. - Wikidata - wikimedia - TriplyDB

Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.

Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.

http://www.wikidata.org/entity/Q33739722

about

Vitamin D Binding Protein Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and Pathologic Conditions.Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial.25-Hydroxivitamin D Serum Concentration, Not Free and Bioavailable Vitamin D, Is Associated with Disease Activity in Systemic Lupus Erythematosus Patients Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays Genetic, Environmental, and Disease-Associated Correlates of Vitamin D Status in Children with CKD.Comparison of Two ELISA Methods and Mass Spectrometry for Measurement of Vitamin D-Binding Protein: Implications for the Assessment of Bioavailable Vitamin D Concentrations Across Genotypes Normalized vitamin D metabolite concentrations are better correlated to pharmacological effects than measured concentrations.Vitamin D and DBP: the free hormone hypothesis revisited.Vitamin D-Binding Protein in Health and Chronic Kidney Disease.Vitamin D Impacts the Expression of Runx2 Target Genes and Modulates Inflammation, Oxidative Stress and Membrane Vesicle Biogenesis Gene Networks in 143B Osteosarcoma Cells.Longitudinal increase in vitamin D binding protein levels after initiation of tenofovir/lamivudine/efavirenz among individuals with HIV.Continued Interest and Controversy: Vitamin D in HIV.

P2860

Q33608600-E86103C6-4898-45BF-A602-F90EBFF3D532 Q34455184-333AC417-6891-4001-B0BA-2C75B1943228 Q34799320-7319A0A7-E3F0-4F37-97E1-306EFC6259D9 Q36249012-955CE176-D4C6-44FD-A76C-AD4E65B72F22 Q36945418-E12F3F7C-DCCC-476A-91CA-824332A993CF Q37047066-7CD87243-430F-422D-84DE-517B5B92A608 Q37069988-561A5729-E337-48B8-87B4-5CA3951E25E3 Q37095215-CFCE4A41-1394-4EC2-A918-4EE6CB2128B0 Q37474227-50398206-15E5-40F9-8F33-A1C8FEC41235 Q37685960-5778BD61-1E93-463C-A5F5-9DE55BF0DC99 Q38579149-5417862D-0B6C-4B24-83BD-8E9BAB7C1966 Q38712047-49FEFB05-F1E7-49DC-B708-AF0A389F387A Q39813500-ADDA6CBB-3F38-416D-A91A-8E298929D428 Q54224147-CB9680D0-A6B5-4C13-9FD4-05F70AC05D91

P2860

Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.

http://www.wikidata.org/entity/Q33739722

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.

@ast

Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.

@en

type

label

Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.

@ast

Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.

@en

prefLabel

Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.

@ast

Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.

@en

P1433

Q33739722-BE84BE55-EA03-46E8-B7D3-6A30C81FDEA6

P1476

Q33739722-D7836382-B9BC-4C36-8F14-E03947A7CF41

P2093

Q33739722-010AD9F7-6CD7-4181-A509-397D958600B9

Q33739722-1F5D571C-B2D9-4AED-9DE5-F4AB31C7183D

Q33739722-20025A02-D428-403A-BCA6-7E48CCBA71CB

Q33739722-2EB79480-2B6F-4815-B3B5-87792A70A0FA

Q33739722-50F0A562-7B38-4120-B094-253E29E270F7

Q33739722-62955D66-D305-4191-8662-B864599F4412

Q33739722-780F9715-FCFF-4265-B035-1BD7CF9654F3

Q33739722-90CA511D-7E8E-4F2A-B805-D2108749B307

Q33739722-9A73C97B-E720-4B9B-924C-BD8DFCDBDE2F

Q33739722-AA499B6B-C434-4D02-AED6-C21D16FBFB4A

P2860

Q33739722-0094FDD5-A481-4EB0-BBF7-22270A0E0DA3

Q33739722-0737BC51-9E2C-4C98-AEDA-C1C6FB13C9AC

Q33739722-15CCC3B5-434F-44C3-80DC-09C353F93287

Q33739722-179D3001-2E7D-49E2-A578-623695929AF2

Q33739722-19AB7CFD-C822-43F8-9FB0-FD3F608C04BA

Q33739722-1E7CB1D9-6E14-4BD6-9622-0244C15DAD27

Q33739722-309BC531-77EC-4CB5-9E9E-A51516418027

Q33739722-387CE71A-F565-47A1-B185-CF1204257B33

Q33739722-3CF6469D-A55F-46C0-A333-F3953F68CAA5

Q33739722-40BEC009-3C80-4EFC-B226-C086D68E0E29

P2888

Q33739722-7E312DD1-CCDC-480F-90B3-A944ADA64B8E

P304

Q33739722-B19D56E6-F0A9-459A-B4D6-6D58E26C903A

P31

Q33739722-3C13FB4B-7176-4808-A125-B28DF792C210

P356

Q33739722-ED572414-702C-41A4-AB08-5949B17D0D61

P433

Q33739722-F68C28F7-B89B-42ED-A6A2-0628CA0A62BF

P478

Q33739722-D2590A74-F955-4908-8D96-9639CEE81767

P577

Q33739722-3790C1CC-08B6-42B7-95BE-C0B3A467A0A5

P6179

Q33739722-BF65C9B9-C20E-4803-85C1-B5E5DB8C535C

P698

Q33739722-62786EA0-5806-4CB1-983F-4341EAD2F2F1

P921

Q33739722-AD2E38BA-5B3E-4E8F-B516-4023F08FC06B

P932

Q33739722-7A2C68A8-BB2B-4073-954D-640F1342460A

P356

S00467-013-2493-9

P1433

Pediatric Nephrology

P1476

Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.

@en

P2093

Anthony Ramirez

http://www.w3.org/2001/XMLSchema#string

Babette S Zemel

http://www.w3.org/2001/XMLSchema#string

Benjamin Laskin

http://www.w3.org/2001/XMLSchema#string

David Stokes

http://www.w3.org/2001/XMLSchema#string

Debbie Foerster

http://www.w3.org/2001/XMLSchema#string

Heidi J Kalkwarf

http://www.w3.org/2001/XMLSchema#string

Ian H de Boer

http://www.w3.org/2001/XMLSchema#string

Justine Shults

http://www.w3.org/2001/XMLSchema#string

Martin Hewison

http://www.w3.org/2001/XMLSchema#string

Mary B Leonard

http://www.w3.org/2001/XMLSchema#string

P2860

Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3)

New equations to estimate GFR in children with CKD

Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production

Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3

Cloning and expression of cDNA encoding 25-hydroxyvitamin D3 24-hydroxylase

Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein.

P2888

s00467-013-2493-9

P304

1843-1853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-013-2493-9

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1036137875

http://www.w3.org/2001/XMLSchema#string

P698

23728936

http://www.w3.org/2001/XMLSchema#string

P921

P932

4053210

http://www.w3.org/2001/XMLSchema#string